This episode explores several global trends, beginning with the surging demand for gold in Asia. Against this backdrop, the discussion pivots to the revolutionary potential of CRISPR gene editing technology, highlighting its applications in medicine and agriculture, including the first CRISPR therapy for sickle cell disease and beta-thalassemia, and the development of gene-edited crops with improved nutritional value. More significantly, the conversation addresses the challenges associated with CRISPR, such as high costs and stringent regulations, and explores potential solutions to accelerate its adoption. For instance, the episode examines how streamlining regulations could expedite the development of personalized CRISPR-based therapies. In contrast, the discussion then shifts to New Zealand's economic struggles and the resulting emigration of its citizens, particularly to Australia, due to factors like high housing costs and perceived lack of opportunities. Finally, the episode concludes by analyzing the complex interplay between cultural traditions and economic factors driving gold consumption in Asia, particularly in India, and the resulting macroeconomic implications.
